Panama Petrochem Faces Decline Amid Broader Sector Weakness and Financial Concerns
Panama Petrochem has reached a new 52-week low, reflecting a year of underperformance with a 29.12% decline. Financial metrics show a low return on capital employed and decreased profit before tax. Despite low debt and healthy long-term growth, caution persists due to limited mutual fund investment.
Panama Petrochem, a small-cap player in the oil industry, has experienced significant activity today, reaching a new 52-week low of Rs.290. This decline reflects a broader trend, as the stock has underperformed its sector by 0.27%. Over the past year, Panama Petrochem's performance has been notably weak, with a decline of 29.12%, contrasting sharply with the Sensex's modest drop of 0.59%.The company's financial metrics reveal some concerning trends. Its return on capital employed (ROCE) stands at a low 19.15%, and profit before tax has decreased by 10.1% compared to the previous four-quarter average, totaling Rs.48.57 crore. Additionally, the company's earnings before interest, taxes, depreciation, and amortization (PBDIT) has also reached a low of Rs.54.86 crore.
Despite these challenges, Panama Petrochem maintains a low debt-to-equity ratio, averaging 0 times, and has shown healthy long-term growth with net sales increasing at an annual rate of 25.82% and operating profit at 42.10%. The stock is currently trading at a fair value relative to its peers, with a price-to-book ratio of 1.4 and a return on equity of 14.9%. However, the lack of domestic mutual fund investment may indicate caution regarding the company's current valuation and business outlook.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
